Kelly L. Bolton

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Kelly L. Bolton, Ryan Ptashkin, Teng Gao et al. · Nature Genetics · 2020 · 696 citations · Full text

Hematological Malignancy, Tumor Heterogeneity, Malignant Blood Disorder +5

Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

Kelly L. Bolton · JAMA · 2012 · 660 citations · Full text

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 606 citations · Full text

Hematological Malignancy, Chromatin, Genome Stability +11

Single-cell mutation analysis of clonal evolution in myeloid malignancies

Linde A. Miles, Robert L. Bowman, Tiffany R. Merlinsky et al. · Nature · 2020 · 500 citations · Full text

Hematological Malignancy, Tumor Heterogeneity, Hematology +7

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Justin Jee, Michael B. Foote, Melissa Lumish et al. · Journal of Clinical Oncology · 2020 · 263 citations · Full text